财务数据关键指标变化 - 公司2024财年净亏损2875061美元，2023财年净亏损64148145美元，2022财年净亏损11838257美元[36] - 截至2024年12月31日，公司营运资金为4419904美元，其中现金及现金等价物为3155750美元[38] - 公司自成立以来有多年净亏损，目前无运营收入，未来短期内也无保证能获得运营收入[36][37] 仲裁事项进展 - 2024年12月13日公司就与墨西哥的投资纠纷提交咨询请求，2024年3月14日通知墨西哥将提交仲裁申请，2024年6月14日启动国际仲裁程序，2025年3月21日提交仲裁纪念文件[35] 股息政策 - 公司自成立以来未支付股息，且可预见的未来也不打算支付[39] - 公司不打算在可预见的未来支付现金股息，收益将用于业务发展和扩张[57] 资源勘探开发业务风险 - 资源勘探开发业务具有投机性，存在发现的矿床数量和质量不足导致无利可图等风险[32] - 公司对矿产产权的调查不构成产权保证，部分物业可能存在未登记协议或产权缺陷[34] - 若勘探开发计划成功，公司需额外资金开发经济矿体并投入商业生产；或需额外资金推进对墨西哥的仲裁程序[40] - 公司勘探活动受广泛法律法规约束，获取许可证过程复杂、耗时，且无法保证能按可接受条款及时获得[42] - 采矿业竞争激烈，即使发现并开发商业数量的矿产资源，也不能保证有盈利市场，矿产价格受多种因素影响而波动[47] 股权相关数据 - 截至2025年4月29日，有1163.5万份流通股购买期权，其中董事和高管持有965万份，非高管员工和顾问持有198.5万份，行使所有期权将使公司已发行和流通普通股增加8%[49] - 截至2025年4月29日，公司有1.37221408亿股已发行和流通普通股[49] 融资风险 - 公司计划通过发行股权证券、举债或两者结合的方式为业务融资，这可能会稀释现有和潜在普通股股东权益[48] 人员依赖与利益冲突 - 公司高度依赖管理层和关键人员，且短期内这种依赖不太可能降低[50] - 公司部分董事和高管在其他自然资源或矿业相关公司任职，可能产生利益冲突[51] 国外业务风险 - 公司在国外的业务面临外汇管制、货币波动、外国税收等风险[52] 法律执行风险 - 公司由加拿大不列颠哥伦比亚省法律合并成立，美国投资者可能难以对非美国居民董事和高管送达法律程序或执行美国法院判决[53] 合规风险 - 公司若违反《采掘业透明度措施法（加拿大）》，可能面临重大处罚或制裁，影响公司声誉[58] 会计标准差异 - 公司作为新兴成长型公司，采用适用于私人公司的会计标准，可能使财务报表难以与其他公司比较[64]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-12154 Waste Management, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employ ...

THE SHERWIN-WILLIAMS COMPANY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2025 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 1-04851 (Registrant's telephone number including area code) | Title of each class | Trading Symbol | Na ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2025 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to . Commission file number 001-10716 TRIMAS CORPORATION (Exact name of registrant as specified in its charter) Delaware 38-2687639 (IRS Empl ...

EXHIBIT 99.1 Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025 April 29, 2025 Contact: Brian Koopman (801) 566-1200 Salt Lake City, Utah – In the first calendar quarter (1Q) of 2025, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent with its previously announced projections for calendar year 2025. Summary of results. The following is a summary comparison of 1Q 2025 with 1Q 2024 income statement measures: | Revenues (Sales): | | | (14.4%) | | --- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ...

or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from __________ to __________ Commission File Number: 0-7617 ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNIVEST FINANCIAL CORPORATION For the quarterly period ended March 31, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Exact name of registrant as specified in its charter) (State or other jurisdiction ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-12317 NOV INC. (Exact name of registrant as specified in its charter) Washington, D.C. 20549 FORM 10-Q Delaware 76-0475815 (State or other jurisdiction of incorporation or organization) (IRS Employ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________________________ ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ...